Partho Sengupta is a Cardiology physician affiliated with Rutgers. OpenAlex indexes 524 publications with 25,100 citations (h-index 75); ClinicalTrials.gov lists 4 registered studies matched to this name. By OpenAlex citation count, this profile ranks in the top 10% of Cardiovascular Disease profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1 Medical Center Dr
Morgantown, WV 265061200
Telephone
304-598-4800Provider last certified this registry record 9 Apr 2024.
Clinical trials
- MyoVista wavECG Clinical Evaluation: >=60 y/o Enrichment Population
Sponsor: Heart Test Laboratories, Inc.
- MyoVista wavECG Clinical Validation Study Versus Low e' on Echocardiogram
Sponsor: Heart Test Laboratories, Inc.
- Role of Cardioflux in Predicting Coronary Artery Disease (CAD) Outcomes
Sponsor: Genetesis Inc.
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
9 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Biosense Webster, Inc.Program year20251 payment
- Medtronic, Inc.Program year20251 payment
- E.R. Squibb & Sons, L.L.C.Program year20252 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
89.1%Beta blocker32.4%Metoprolol Succinate84%Labetalol Hcl16%Part D<11 patientsStatin25.9%Atorvastatin Calcium78%Rosuvastatin Calcium22%Part D<11 patients+ 3 more classes in this area
Blood & clotting
10.9%Factor Xa inhibitor10.9%Eliquis100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Deep-Learning Models for the Echocardiographic Assessment of Diastolic Dysfunction
JACC. Cardiovascular imaging
2021 - Proposed Requirements for Cardiovascular Imaging-Related Machine Learning Evaluation (PRIME): A Checklist
JACC. Cardiovascular imaging
2020 - High Prevalence of Pericardial Involvement in College Student Athletes Recovering From COVID-19
JACC. Cardiovascular imaging
2020 - Screening of Potential Cardiac Involvement in Competitive Athletes Recovering From COVID-19
JACC. Cardiovascular imaging
2020
Similar KOLs
Other experts from the same institution or the same specialty.
Reynold Panettieri, MD
Rutgers
Jacob Sage, MD
Rutgers
Brenda Kurnik, MD
Rutgers
Dale Schaar
Rutgers
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Harlan Krumholz, MD
Yale School of Medicine
Scott Solomon, MD
Brigham and Women's Hospital
Eric Topol, MD
Scripps Research Institute (Scripps Research)
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”